Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 98
Filter
1.
Rev Neurol ; 78(8): 219-228, 2024 Apr 16.
Article in Spanish | MEDLINE | ID: mdl-38618669

ABSTRACT

INTRODUCTION: Dual-tasking is a non-pharmacological intervention in people with neurodegenerative conditions, and is used in Parkinson's disease (PD), primarily to enhance motor performance. The aim of this review is to compile the current evidence on how dual-task training affects cognitive processes in people with PD. MATERIAL AND METHODS: A systematic review was undertaken, applying PRISMA guidelines, which included articles obtained from the PubMed, Web of Science, Science Direct and Springer Link databases. Methodological quality was assessed using PEDro and ROBINS-I. RESULTS: Twelve articles met the inclusion and exclusion criteria: nine of them were randomized controlled trials, and the remaining three were non-randomized studies. Improvements in attention and executive functions were identified, although the diversity of approaches and duration means that reaching definitive conclusions is difficult. CONCLUSIONS: Increased research and standardized intervention programmes are essential. Longitudinal and randomized controlled studies in representative samples which provide conclusions that are applicable to other contexts are also important.


TITLE: Efectos sobre los procesos cognitivos del entrenamiento basado en doble tarea en personas con enfermedad de Parkinson: una revisión sistemática.Introducción. La doble tarea es una intervención no farmacológica en personas con condiciones neurodegenerativas, utilizada en la enfermedad de Parkinson (EP), principalmente para favorecer el desempeño motor. El objetivo de esta revisión es reunir la evidencia actual sobre cómo el entrenamiento de doble tarea afecta a los procesos cognitivos en personas que presenten EP. Material y métodos. Se desarrolló una revisión sistemática, aplicando las directrices de PRISMA, incluyendo artículos obtenidos en las bases de datos de PubMed, Web of Science, Science Direct y Springer Link. La calidad metodológica se evaluó mediante PEDro y ROBINS-I. Resultados. Doce artículos cumplieron con los criterios de inclusión y exclusión: nueve de ellos corresponden a ensayos controlados aleatorizados y los tres restantes fueron estudios no aleatorizados. Se identificaron mejoras en la atención y las funciones ejecutivas, aunque la diversidad en enfoques y duración dificulta llegar a conclusiones definitivas. Conclusiones. Es crucial expandir la investigación, estandarizando los programas de intervención. Del mismo modo, es importante llevar a cabo estudios longitudinales y controlados aleatorizados en muestras representativas que permitan llegar a conclusiones aplicables a otros contextos.


Subject(s)
Cognition , Parkinson Disease , Parkinson Disease/psychology , Parkinson Disease/therapy , Parkinson Disease/rehabilitation , Humans , Executive Function , Attention , Randomized Controlled Trials as Topic
2.
Rev. ANACEM (Impresa) ; 17(1): 102-106, 2023. tab, ilus
Article in Spanish | LILACS | ID: biblio-1526312

ABSTRACT

Introducción: La depresión es un trastorno del ánimo frecuente, cuya recurrencia altera su manejo y pronóstico. El objetivo del trabajo es describir la tasa de egreso hospitalario (TEH) por episodio depresivo recurrente (EDR) entre 2018-2021 en Chile, según sexo, edad y gravedad. Materiales y métodos: Estudio observacional y transversal que considera los egresos hospitalarios por EDR en el período 2018-2021 en Chile (N=1551). Se utilizaron las bases de datos del Departamento de Estadísticas e Información de Salud y el Instituto Nacional de Estadística. Las variables estudiadas fueron sexo, grupo etario y gravedad. No requirió aprobación de comité de ética. Resultados: Se observó la menor TEH en 2020 con 1,91 egresos por cada 100.000 habitantes. Las mujeres sobresalieron durante todo el período con una TEH de 3,68 egresos por cada 100.000 habitantes. Destacó el grupo de 15 a 19 años con la mayor TEH en ambos sexos con 5,3 egresos por cada 100.000 habitantes. Respecto a gravedad, las hospitalizaciones se concentraron en pacientes de diagnóstico no especificado. Discusión: La pandemia de COVID 19 podría explicar la disminución de la TEH en 2020, al reducirse el diagnóstico y hospitalización por EDR; presumiblemente debido al fenómeno de reconversión de camas. La TEH es mayor en el sexo femenino, lo cual es concordante con la literatura. El predominio del grupo de 15 a 19 años discrepa de la evidencia, la cual indica que suele concentrarse en individuos de 25 a 64 años. Conclusión: Las TEH por EDR se concentraron en mujeres jóvenes. Es relevante conocer la epidemiología local para focalizar los recursos en la detección oportuna de factores de riesgo, para evitar episodios graves y disminuir su recurrencia.


Introduction: Depression is a common mood disorder, whose recurrence alters its management and prognosis. The aim of the paper is to describe the hospital discharge rate (HED) for recurrent depressive episode (RDE) between 2018-2021 in Chile, according to sex, age and severity. Materials and methods: Observational and cross-sectional study considering hospital discharges due to DRE in the period 2018-2021 in Chile (N=1551). The databases of the Department of Health Statistics and Information and the National Institute of Statistics were used. The variables studied were sex, age group and severity. Ethics committee approval was not required. Results: The lowest HTE was observed in 2020 with 1.91 discharges per 100,000 inhabitants. Females stood out during the entire period with an HTE of 3.68 discharges per 100,000 population. The 15-19 years age group stood out with the highest HTE in both sexes with 5.3 admissions per 100,000 inhabitants. In terms of severity, hospitalizations were concentrated in patients with unspecified diagnosis. Discussion: The COVID 19 pandemic could explain the decrease in HTE in 2020, with a reduction in diagnosis and hospitalization for RDE, presumably due to the bed conversion phenomenon. HTE is higher in the female sex, which is consistent with the literature. The predominance of the 15 to 19 years age group disagrees with the evidence, which indicates that it tends to be concentrated in individuals aged 25 to 64 years. Conclusion: HTE due to DRE was concentrated in young women. It is important to know the local epidemiology in order to focus resources on the timely detection of risk factors to avoid serious episodes and reduce their recurrence.


Subject(s)
Humans , Male , Female , Child , Adolescent , Adult , Middle Aged , Aged , Aged, 80 and over , Young Adult , Depressive Disorder/epidemiology , Psychiatric Department, Hospital , Epidemiology, Descriptive , Hospitalization/statistics & numerical data , Medical Records Department, Hospital
3.
Rev. chil. endocrinol. diabetes ; 16(4): 121-123, 2023.
Article in Spanish | LILACS | ID: biblio-1512165

ABSTRACT

Los inhibidores de checkpoint (ICP) son anticuerpos usados en inmunoterapia contra el cáncer. Uno de sus blancos de acción es el receptor de muerte celular programada-1 (PD-1), el cual es importante para mantener la tolerancia inmunitaria. Sin embargo, este mecanismo se asocia a riesgo de eventos adversos relacionados a la inmunidad que pueden afectar a múltiples órganos incluyendo el sistema endocrino. Se describe el caso inhabitual de un paciente que a los 18 meses de terapia con ICP debutó con cetoacidosis diabética (CAD).


Immune checkpoint inhibitors consist in antibodies used in immunotherapy against cancer. One of their targets is the programmed cell death-1 (PD-1) receptor, which is important in maintaining self-tolerance. However, this mechanism is associated with a risk for immune-related adverse events potentially affecting multiple organs, including the endocrine system. We describe the unusual case of a patient who, after 18 months of treatment with an immune checkpoint inhibitor, debuted with diabetic ketoacidosis


Subject(s)
Humans , Male , Middle Aged , Diabetic Ketoacidosis/chemically induced , Antibodies, Monoclonal, Humanized/adverse effects , Immune Checkpoint Inhibitors/adverse effects , Skin Neoplasms/drug therapy , Diabetic Ketoacidosis/immunology , Diabetes Mellitus/chemically induced , Cell Cycle Checkpoints , Antineoplastic Agents, Immunological/adverse effects , Immunotherapy/adverse effects , Melanoma/drug therapy
4.
Rev. cir. (Impr.) ; 74(4): 345-353, ago. 2022. tab, graf
Article in Spanish | LILACS | ID: biblio-1407936

ABSTRACT

Resumen Introducción: En los últimos años, la gastrectomía laparoscópica ha aparecido como una técnica quirúrgica con resultados oncológicos comparables a la técnica abierta, pero existe poca evidencia en cuanto a la calidad de vida posoperatoria de estos pacientes. Objetivo: Evaluar la calidad de vida posoperatoria de pacientes sometidos a gastrectomía total laparoscópica (GTL) en comparación a gastrectomia total abierta (GTA) en cáncer gástrico. Materiales y Método: Estudio retrospectivo, observacional en Hospital Militar de Santiago, entre enero de 2015 y junio de 2020. Se les aplicó 2 encuestas validadas para Chile: EORTC QLQ-30 y EORTC QLQ-OG25. Resultados: Se obtuvieron 60 pacientes; 30 sometidos a GTL y 30 a GTA. Promedio edad fue 66,3 ± 11 años para GTL y 68,2 ± 11 años en GTA (p = 0,5). Se obtuvo un score en GTL versus GTA: global 83,3 y 80,2 (p = 0,6), sintomático 17,1 y 25,5 (p = 0,2) y score funcional 87,9 y 70,9 (p = 0,03). Posterior a eso obtuvimos en funcionalidad GTL versus GTA; física 92,2 versus GTA 73,1 (p = 0,04), emocional 84,1 versus 78,5 (p = 0,6), cognitiva 84,9 versus 79,0 (p = 0,3) y social 80,9 versus 72,2 (p = 0,4). Al analizar síntomas destaco; fatiga 14,6 versus 33,1 (p = 0,04) y dolor 13,4 versus 24,3 (p = 0,05). Finalmente, en síntomas digestivos altos obtuvimos en disfagia 0,84 GTL versus 17,3 GTA (p = 0,04). Conclusión: La GTL logra resultados comparables a GTA en calidad de vida e incluso ofrece ventajas significativas en funcionalidad física como también en síntomas como dolor, fatiga y disfagia.


Introduction: In recent years, laparoscopic gastrectomy has appeared as a surgical technique with oncological results comparable to the open technique, but there is little evidence regarding the postoperative quality of life of these patients. Objective: To evaluate the postoperative quality of life of patients undergoing laparoscopic total gastrectomy (LTG) compared to open total gastrectomy (OTG) in gastric cancer. Materials and Method: Prospective, observational study at Hospital Militar of Santiago, between January 2015 and June 2020. Two surveys validated for Chile were applied: EORTC QLQ-30 and EORTC QLQ-OG25. Results: 60 patients were obtained; 30 subjected to LTG and 30 to OTG. Average age was 66.3 ± 11 years for LTG and 68.2 ± 11 years for OTG (p = 0.5). A score was obtained in LTG versus OTG: global 83.3 and 80.2 (p = 0.6), symptomatic 17.1 and 25.5 (p = 0.2) and functional score 87.9 and 70.9 (p = 0.03). After that we got LTG versus OTG functionality; physical 92.2 versus 73.1 (p = 0.04), emotional 84.1 versus 78.5 (p = 0.6), cognitive 84.9 versus 79.0 (p = 0.3) and social 80.9 versus 72.2 (p = 0.4). When analyzing symptoms I highlight; fatigue 14.6 versus 33.1 (p = 0.04) and pain 13.4 versus 24.3 (p = 0.05). Finally, in upper digestive symptoms, we obtained 0.84 LTG versus 17.3 OTG in dysphagia (p = 0.04). Conclusion: LTG achieves results comparable to OTG in quality of life and even offers significant advantages in physical functionality as well as symptoms such as pain, fatigue and dysphagia.


Subject(s)
Humans , Male , Female , Child , Middle Aged , Quality of Life , Stomach Neoplasms/surgery , Adenocarcinoma/surgery , Gastrectomy/adverse effects , Demography , Surveys and Questionnaires , Retrospective Studies
5.
Rev. méd. Chile ; 149(11): 1544-1551, nov. 2021. tab, graf
Article in Spanish | LILACS | ID: biblio-1389389

ABSTRACT

BACKGROUND: The overall mortality of patients with COVID-19 admitted to intensive care units is approximately 40%. Aim: To describe the characteristics of a cohort of patients with COVID-19 who required invasive mechanical ventilation due to severe hypoxemic acute respiratory failure at a general hospital in Santiago, Chile. MATERIAL AND METHODS: Review of medical records and follow up for 28 days of patients with COVID-19 confirmed by polymerase chain reaction who required invasive mechanical ventilation and who were admitted to the intensive care unit from March 24 to June 7, 2020. RESULTS: Data from 152 patients aged 58 (interquartile range (IQR) 47-65 years (66% men) was analyzed. As of July 5, 36 (24%) had died, 75 (49%) were discharged, 10 (7%) were still on invasive mechanical ventilation, 11 (7%) remained with tracheostomy but without invasive mechanical ventilation, and 20 (13%) were hospitalized in a basic unit. The median time on invasive mechanical ventilation among extubated patients was 14 days (IQR 10-21) and 121 (80%) were in the prone position. Patients who died were older, had a higher frequency of diabetes mellitus and a higher driving pressure at 7 days than those discharged alive from the intensive care unit. Conclusions: In this study mortality was lower than that reported in the first international studies, probably due to the selection of younger patients and greater knowledge of the disease.


Subject(s)
Humans , Male , Female , COVID-19/therapy , Respiration, Artificial , Retrospective Studies , SARS-CoV-2 , Hospitalization , Intensive Care Units
6.
Rev Med Chil ; 149(11): 1544-1551, 2021 Nov.
Article in Spanish | MEDLINE | ID: mdl-35735316

ABSTRACT

BACKGROUND: The overall mortality of patients with COVID-19 admitted to intensive care units is approximately 40%. AIM: To describe the characteristics of a cohort of patients with COVID-19 who required invasive mechanical ventilation due to severe hypoxemic acute respiratory failure at a general hospital in Santiago, Chile. MATERIAL AND METHODS: Review of medical records and follow up for 28 days of patients with COVID-19 confirmed by polymerase chain reaction who required invasive mechanical ventilation and who were admitted to the intensive care unit from March 24 to June 7, 2020. RESULTS: Data from 152 patients aged 58 (interquartile range (IQR) 47-65 years (66% men) was analyzed. As of July 5, 36 (24%) had died, 75 (49%) were discharged, 10 (7%) were still on invasive mechanical ventilation, 11 (7%) remained with tracheostomy but without invasive mechanical ventilation, and 20 (13%) were hospitalized in a basic unit. The median time on invasive mechanical ventilation among extubated patients was 14 days (IQR 10-21) and 121 (80%) were in the prone position. Patients who died were older, had a higher frequency of diabetes mellitus and a higher driving pressure at 7 days than those discharged alive from the intensive care unit. CONCLUSIONS: In this study mortality was lower than that reported in the first international studies, probably due to the selection of younger patients and greater knowledge of the disease.


Subject(s)
COVID-19 , COVID-19/therapy , Female , Hospitalization , Humans , Intensive Care Units , Male , Respiration, Artificial , Retrospective Studies , SARS-CoV-2
7.
Ultrasonics ; 107: 106161, 2020 Sep.
Article in English | MEDLINE | ID: mdl-32402859

ABSTRACT

In this work, we have developed numerical simulations and weakly nonlinear analysis based on the multiple-scales perturbation technique for a coated microbubble that performs radial pulsations subject to an acoustic pressure disturbance in the far-field and whose encapsulated hyperelastic material obeys the Mooney-Rivlin equation. Departing from an elastic coating as a hyperelastic shell of finite thickness, we assume eventually that the shell is of very small thickness in comparison with the microbubble radius. Under this condition, we then perform weakly nonlinear analysis, to identify resonance conditions for small pressure disturbances of the acoustic field. In parallel and also for the limit of small thickness, we have carried out numerical simulations of the radial motion of the microbubble, identifying the onset of limit cycles via the construction of Poincare maps. Under both schemes, we have recognized the importance of two dimensionless hyperelastic parameters that dictate the main behavior of the oscillations: α∗ and ß∗. Decreasing the values of these parameters, the resonance conditions are drastically amplified, which is an expected result because of the weak rigidity of the hyperelastic solid, prevails. In this manner, we suggest that moderate values for these previous parameters can be widely advisable when, in medical diagnostic applications, we are applying microbubbles as contrast agents. Therefore, we recommend widely the use of shell softens, because in this case the amplitude of radial pulsation is always amplified.

9.
J Mycol Med ; 28(4): 663-665, 2018 Dec.
Article in English | MEDLINE | ID: mdl-30126716

ABSTRACT

Chromoblastomycosis is defined as a chronic cutaneous and subcutaneous fungal infection caused by melanized or brown-pigmented fungi. A 63-year-old man farmer showed on external and internal part of the right arm, a well-delimited verrucous and hyperkeratotic plaque, with atrophic and cicatricial areas. Direct examination of skin scrapings samples showed the presence of muriform cells, a classic feature of chromoblastomycosis. Fungal isolation was performed in Sabouraud dextrose agar, and dark olivaceous colonies were isolated. Skin biopsy samples were obtained for histopathological and molecular diagnosis. DNA extracted from both, paraffin-embedded skin biopsy samples and fungal colonies, was used for molecular identification by 18S-ITS1-5.8S-ITS2-28S rRNA amplification and sequencing. Fonsecaea pedrosoi was identified from paraffin-embedded skin samples and fungal colonies. A combined therapy with terbinafine and itraconazole, plus cryotherapy was applied with an important improvement. Herein, we report an impressive case of chromoblastomycosis due to Fonsecaea pedrosoi with a successful outcome.


Subject(s)
Ascomycota/isolation & purification , Chromoblastomycosis/diagnosis , Chromoblastomycosis/therapy , Antifungal Agents/therapeutic use , Ascomycota/cytology , Ascomycota/drug effects , Ascomycota/genetics , Chromoblastomycosis/pathology , Combined Modality Therapy , Cryotherapy , DNA, Fungal/genetics , DNA, Ribosomal Spacer/genetics , Genome, Fungal/genetics , Humans , Itraconazole/therapeutic use , Male , Middle Aged , Sequence Analysis, DNA , Skin/microbiology , Skin/pathology , Terbinafine/therapeutic use , Treatment Outcome
10.
Rev. chil. cir ; 70(4): 342-349, ago. 2018. tab, ilus
Article in Spanish | LILACS | ID: biblio-959393

ABSTRACT

Resumen Introducción: El tratamiento de los tumores estromales gastrointestinales (GIST) de alto riesgo es quirúrgico. Su resultado podría variar al usarse neoadyuvancia. Objetivo: Evaluar si el uso de la terapia neoadyuvante con imatinib puede cambiar el abordaje quirúrgico en los tumores estromales gastrointestinales de alto riesgo. Materiales y Métodos: Se realizó un análisis retrospectivo en el Hospital Clínic de Barcelona entre enero de 2002 y mayo de 2016. Resultados: Se obtuvo un total de 8 pacientes. La edad media fue 66,1 ± 13,3 años. La ubicación del tumor fue de 37,5% (3) en el tercio superior, el 50% (4) en el tercio medio y el 12,5% (1) en el tercio inferior. Debido a la clasificación de riesgo alto, la ubicación y/o la necesidad de resecciones multiviscerales, se indicó, previa evaluación comité oncológico, realizar terapia neoadyuvante. La mediana de tiempo de neoadyuvancia fue de 30 semanas. En el 100% (8) de los casos se logró un cambio de enfoque quirúrgico después de la utilización de imatinib. En todos los casos se realizó un resección local (7 laparoscópica y 1 endolaparoscópica) con márgenes negativos La biopsia posoperatoria mostró un promedio de 51,2% de reducción del tamaño tumoral inicial, lo que resultó en una diferencia estadística (p < 0,01) con el tamaño inicial de las lesiones. Durante el seguimiento, tanto la sobrevida relacionada al tumor como la global, fue de un 100%. Conclusión: La terapia neoadyuvante podría cambiar el abordaje quirúrgico de los pacientes con GIST gástrico de riesgo intermedio o alto mediante la reducción del tamaño tumoral, permitiendo realizar cirugías más económicas y logrando resultados oncológicos adecuados.


Introduction: The treatment of high-risk gastrointestinal stromal tumors (GIST) is surgical. Results may change when using neoadjuvant. Objetive: To evaluated if the use of neoadjuvant therapy with imatinib can change the surgical approach in high risk gastrointestinal stromal tumors (GIST). Materials and Methods: A retrospective analysis was performed from a prospective collected database in Hospital Clinic of Barcelona between January 2002 and May 2016. Results: A total of 8 patients were analyzed with a mean age of 66.1 ± 13.3 years. The tumor location was upper third 37.5% (3) cases, 50% (4) in the middle third and 12.5% (1) in lower third. Because of high risk classification, location and the need of multivisceral resections, neoadjuvant therapy was indicated. The median time of neoadjuvant therapy was 30 weeks. In 87.5% (7) cases a change of surgical approach was achieved after the use of imatinib. In 100% of our series laparoscopic wedge resection was performed achieving negative margins of resection. The postoperative biopsy showed 51.2% of reduction of initial tumor size, resulting in statistical difference (p < 0.01). All patients are alive and 100% of tumor related survival was achieved. Conclusion: Neoadjuvant therapy maybe can change the surgical approach of patients with high-intermediate risk gastric GIST by reducing tumor size. This response also eventually can achieve optimal oncological outcome.


Subject(s)
Humans , Male , Female , Adult , Middle Aged , Aged , Aged, 80 and over , Stomach Neoplasms/drug therapy , Neoadjuvant Therapy/methods , Gastrointestinal Stromal Tumors/drug therapy , Imatinib Mesylate/therapeutic use , Antineoplastic Agents/therapeutic use , Stomach Neoplasms/surgery , Retrospective Studies , Treatment Outcome , Laparoscopy , Gastrointestinal Stromal Tumors/surgery
11.
Anat Histol Embryol ; 47(2): 110-118, 2018 Apr.
Article in English | MEDLINE | ID: mdl-29205465

ABSTRACT

The available information about anatomical characteristics of the cardiovascular system of the alpaca (Vicugna pacos, Linnaeus 1758) is scarce. The general objective of this work was to describe its heart anatomy. We dissected six adult animals and five neonates. The heart of the alpaca was located in the middle mediastinum, with a craniocaudal extension from the third to the sixth rib. No ligament that connected the fibrous pericardium to the sternum or to the diaphragm was detected. In the right atrium, there was a developed crista terminalis and small pectinate muscles. In the right ventricle, the septomarginal trabecula was very large. From the proximities of the interventricular septum arose small septomarginal trabeculae that ended in carnous trabeculae of the septal wall. The left atrium included little developed pectinate muscles. On the left ventricle, both papillary muscles were bilobed. Two left septomarginal trabeculas were detected in this ventricle. The left subclavian artery was originated from the aortic arch separately from the brachiocephalic trunk, and bicarotid trunk was present. The other branches of the subclavian artery were similar to the domestic ruminants. The arterial supply of the heart was of the right type. In conclusion, the heart anatomy of alpaca and the irrigation of thoracic cavity were more similar to those of old world camels and different from domestic ruminants.


Subject(s)
Camelids, New World/anatomy & histology , Dissection/veterinary , Heart Atria/anatomy & histology , Heart Ventricles/anatomy & histology , Thoracic Cavity/blood supply , Animals , Aorta, Thoracic/anatomy & histology , Female , Male , Myocardium , Papillary Muscles/anatomy & histology , Subclavian Artery/anatomy & histology
12.
J Comp Pathol ; 157(2-3): 163-173, 2017.
Article in English | MEDLINE | ID: mdl-28942299

ABSTRACT

The black rat (Rattus rattus) is an invasive species and potential reservoir of significant pathogens of man, domestic animals and wildlife. During the 2012-2014 austral summers, 201 black rats were captured and examined on the uninhabited Guafo Island, in Northern Chilean Patagonia (43.593029°S, 74.713481°W). The mite Ornithonyssus bacoti caused lymphoplasmacytic and eosinophilic dermatitis in all infected rats (105/210, 52%), but no skin lesions were observed in rats infected with Nosopsyllus spp. and Plocopsylla spp. fleas. Eighty-eight rats (44%) had mild lymphoplasmacytic and eosinophilic enterocolitis and 61 of these rats were infected with the nematode Heterakis spumosa. In the liver, 63 animals (31%) had areas of necrosis with histiocytic and eosinophilic inflammation associated with multiple Calodium hepaticum eggs, and in 15 cases there was co-infection with several Taenia taeniaeformis strobilocerci. Mild interstitial lymphoplasmacytic sialadenitis with intranuclear inclusion bodies, suggesting cytomegalovirus infection, was observed in 28 rats (15%). In the lung, alveolar histiocytosis (69 rats, 34%) and perivascular lymphocytic infiltrates (46 rats, 23%) were the most common findings. There was mild to moderate lymphoplasmacytic interstitial nephritis in 52 rats (26%) and in 15% of these cases Leptospira spp. antigen was detected in the distal renal tubules. Some of the diseases of black rats on Guafo Island are likely to play a role in rat population dynamics. The endemic Guafo Island long-clawed mole mouse (Geoxus lafkenche), sea lions and fur seals may be at risk for infection by some of these rat pathogens.


Subject(s)
Animals, Wild , Rodent Diseases/epidemiology , Rodent Diseases/etiology , Animals , Chile , Disease Reservoirs , Rats
13.
Genet Mol Res ; 14(3): 8100-16, 2015 Jul 17.
Article in English | MEDLINE | ID: mdl-26214493

ABSTRACT

Xylan is a heteropolysaccharide and its complete hydrolysis involves a complex set of xylanolytic enzymes. Fungal xylanases have been widely used in the holocellulose industry to obtain by-products or for its elimination. The aim of this study was to select and identify filamentous fungi from different ecosystems that produce extracellular xylanases showing biotechnological potential. One hundred three fungal isolates were obtained from orchard, horticultural, and forest ecosystems. The ability of fungi to degrade xylan was measured by quantifying their xylanolytic indices after growth on solid culture media and their extracellular xylanolytic and cellulolytic activities after submerged fermentation. All fungal isolates grew on solid medium supplemented with xylan as the sole carbon source, but only 44% of isolates showed xylanolytic indices greater than 1.0. In submerged fermentation, 39% of the fungi tested showed no cellulolytic activity. Filamentous fungi were chosen from correspondence analysis and were identified by molecular tools using internal transcribed spacers. One of the 9 isolates selected belonged to the Phoma genus and the remaining were from the Fusarium genus. Fusarium solani (isolate 59) showed the highest xylanolytic index (0.964 ± 0.042), rapid growth on solid medium (1.233 ± 0.050 cm/day), significant xylanolytic activity (3.823 ± 0.210 U/mg), and a total deficiency of cellulolytic activity compared to other fungal isolates. In the zymogram, a clear zone was observed, indicating that F. solani possesses at least 1 xylanase. Fusarium solani was selected for its ability to produce extracellular xylanases with biotechnological potential.


Subject(s)
Endo-1,4-beta Xylanases/metabolism , Fungal Proteins/metabolism , Fungi/enzymology , Fungi/isolation & purification , Xylans/metabolism , Cellulose/metabolism , Electrophoresis, Polyacrylamide Gel , Polymerase Chain Reaction
14.
Pediatr Blood Cancer ; 61(5): 803-9, 2014 May.
Article in English | MEDLINE | ID: mdl-24376115

ABSTRACT

BACKGROUND: Five Asociación de Hemato-Oncología de Centroamérica (AHOPCA) countries have used an adapted BFM-based protocol for childhood acute lymphoblastic leukemia (ALL). PROCEDURE: In the AHOPCA-ALL 2008 protocol, patients were stratified by age, white blood cell count, immunophenotype, central nervous system involvement, day 8 prednisone response, and morphologic bone marrow response to induction therapy. Patients at Standard Risk (SR) received a three-drug induction regimen, a reinduction phase, and maintenance with protracted intrathecal therapy. Those at Intermediate (IR) and High Risk (HR) received, in addition, daunorubicin during induction therapy, a consolidation phase and two or three reinduction phases respectively. RESULTS: From August 2008 through July 2012, 1,313 patients were enrolled: 353 in SR, 548 in IR, 412 in HR. During induction therapy, 3.0% of patients died, 2.7% abandoned treatment, 1.1% had resistant ALL, and 93.2% achieved morphological complete remission (CR). Deaths and abandonment in first CR occurred in 2.7% and in 7.0% of patients, respectively. The relapse rate at a median observation time of 2.1 years was 15.0%. At 3 years, the event-free survival (EFS) and overall survival (OS), with abandonment considered as an event, were 59.4% (SE 1.7) and 68.2% (SE 1.6). Three-year EFS was 68.5% (SE 3.0), 62.1% (SE 2.6), and 47.8% (SE 3.2) for SR, IR, and HR groups. Adolescents had a significantly higher relapse rate (P = 0.001). CONCLUSIONS: This experience shows that common international studies are feasible in lower-middle income countries. Toxic deaths, abandonment of treatment, and relapses remain major obstacles to the successful treatment. Alternative treatment strategies may be beneficial.


Subject(s)
Developing Countries , Neoplasm Recurrence, Local/therapy , Neoplasms, Second Primary/therapy , Precursor Cell Lymphoblastic Leukemia-Lymphoma/therapy , Withholding Treatment/statistics & numerical data , Adolescent , Central America , Child , Child, Preschool , Combined Modality Therapy , Female , Follow-Up Studies , Humans , Immunophenotyping , Income , Infant , Infant, Newborn , Male , Neoplasm Recurrence, Local/etiology , Neoplasm Recurrence, Local/mortality , Neoplasms, Second Primary/etiology , Neoplasms, Second Primary/mortality , Poverty , Precursor Cell Lymphoblastic Leukemia-Lymphoma/complications , Precursor Cell Lymphoblastic Leukemia-Lymphoma/mortality , Prognosis , Remission Induction , Survival Rate , Withholding Treatment/economics
15.
Rev. ANACEM (Impresa) ; 7(3): 142-144, dic.2013. tab
Article in Spanish | LILACS | ID: lil-779302

ABSTRACT

La Polirradiculoneuropatía Desmielinizante Inflamatoria Crónica (PDIC) es un desorden adquirido de los nervios periféricos y las raíces nerviosas, que se desarrolla de forma continua durante ocho semanas o más. La forma clásica se caracteriza por compromiso simétrico sensitivo y motor, la debilidad está presente tanto en musculatura proximal como distal y es característico en el estudio electrofisiológico la desmielinización junto a disociación albúmino-citológica en Líquido Cefalorraquídeo (LCR). PRESENTACION DEL CASO. Mujer de 34 años con antecedente de depresión en tratamiento, inicia hace un año aproximadamente debilidad muscular de las cuatro extremidades, ascendente y progresiva, llegando a la incapacidad de la marcha. Ingresó al servicio de urgencia del hospital de Puerto Montt, con paraparesia predominante en extremidades inferiores, hipoestesia y ausencia de reflejos osteotendinosos. Estudio electrofisiológico evidencia severa polineuropatía sensitivamotora desmielinizante con degeneración axonal secundaria.LCR con proteinorraquia de 100 mg/dl y sin celularidad. Inició tratamiento con corticoides y luego plasmaféresis, evolucionando con mejoría significativa de la funcionalidad y marcha independiente. DISCUSIÓN. Las principales modalidades terapéuticas de PDIC son la inmunoglobulina intravenosa, glucocorticoides y plasmaféresis. Todos estos parecen ser igualmente efectivos de forma separada. La elección está influenciada por las preferencias del paciente, efectos adversos, costo, duración y disponibilidad. El uso de inmunoglobulina intravenosa es a veces limitado; los corticoides son económicos, pero con efectos adversos frecuentes y relevantes; y la plasmaféresis es cara, invasiva y solamente disponible en centros especializados. La mayoría de los pacientes, responden inicialmente, pero las recaídas son frecuentes...


INTRODUCTION. Chronic inflammatory demyelinating polyradiculoneuropathy(CIDP) is an acquired disorder of peripheral nerves and nerve roots that run continuously for 8 weeks or more. The classic form is characterized by symmetric sensory and motor involvement, weakness is present in both proximal and distal muscles and is characteristic in the electrophysiological study demyelination with albumin-cytological dissociation in cerebrospinal fluid (CSF). PRESENTATION OF THE CASE.34-year-old woman with a history of depression in treatment, started about a year ago muscle weakness of all limbs, ascending and progressive, leading to the inability of the march. Was admitted with paraparesis, predominantly in lower extremities, hypoesthesia and absence of tendon reflexes. Electrophysiological study evidence severe demyelinating motor sensory polyneuropathy with secondary axonal degeneration. CSF protein concentration of 100 mg / dL and no cellularity. Starts treatment with corticosteroids and plasmapheresis, evolving with significant improvement in functionality and independent walking. DISCUSSION. The main therapeutic modalities in CIDP are intravenous immunoglobulin, corticosteroids and plasmapheresis. All these seem to be equally effective separately. The choice is influenced by patient preference, adverse effects, cost, duration and availability. The use of intravenous immunoglobulinis sometimes limited; corticosteroids are inexpensive, but with frequent and significant side effects; and plasmapheresis is expensive, invasive and only available at specialized centers. Most patients respond initially but relapses are frequent...


Subject(s)
Humans , Adult , Female , Anti-Inflammatory Agents , Methylprednisolone/therapeutic use , Plasmapheresis , Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
16.
Article in Spanish | LILACS | ID: lil-660043

ABSTRACT

La periodontitis crónica es una patología infecciosa, causada por un complejo de especies bacterianas, que afecta principalmente los tejidos de inserción de los dientes. La respuesta inmune-inflamatoria producida se caracteriza por la presencia de un infiltrado inflamatorio, en el cual los macrófagos representan entre 5 al 30 por ciento. Es sabido que los macrófagos se activan mediante dos vías: Clásica y Alterna, caracterizadas por la presencia de marcadores indirectos: IFN-y e IL-6 para la vía clásica e IL-4 para la vía alterna, ampliamente abordados. Recientemente, se ha descrito a la subunidad A del factor XIII de la coagulación (FXIII-A) como un buen marcador de la vía alterna. El objetivo de este estudio consiste en determinar la presencia de IFN-y, IL-6, FXIII-A e IL-4 como marcadores de las vías de activación de los macrófagos, en pacientes con periodontitis crónica. Para tal efecto, se realizó inmunohistoquímica y Western-Blot para los cuatro marcadores junto a CD-68, marcador de macrófagos, en 18 biopsias de tejido periodontal sano y 18 con periodontitis crónica. Se detectó la presencia de IFN-y, IL-6, IL-4 y FXIII-A junto a CD68+, en todas las muestras de pacientes sanos y con periodontitis. Los resultados obtenidos sugieren que al estar presente IFN-y, IL-6, IL-4 y FXIII-A, los macrófagos se activarían a través de ambas vías, lo cual, produciría una respuesta tanto proinflamatoria (Th1) como antinflamatoria (Th2). Son necesarios más estudios para determinar si existe una vía preferencial de activación.


Periodontitis is a chronic infectious disease caused by a bacterial species complex, which affects mainly the insertion tissues of the teeth. The immune-inflammatory response produced is characterized by an inflammatory infiltrate in which macrophages represent between 5 to 30 percent. It is known and has been widely discussed that macrophages are activated in two ways: Classical and Alterna, characterized by the presence of indirect markers: IFN-y and IL-6 for the classical pathway and IL-4 for the alternative pathway. Recently the subunit A of the clotting factor XIII (FXIII-A) has been described as a good marker of the alternative pathway. The objective of this study is to determine the presence of IFN-y, IL-6, IL-4 and FXIII-A as markers of the macrophage activation pathways in patients with chronic periodontitis. To this end, we performed immunohistochemistry and Western blot for the four markers with CD68 macrophage marker, in 18 healthy periodontal tissue biopsies and 18 with chronic periodontitis. We detected the presence of IFN-y, IL-6, IL-4 and FXIII-A with CD68 +, in all samples of healthy patients and periodontitis. The results suggest that when present, IFN-y, IL-6, IL-4 and FXIII-A, activate macrophages through both routes, which would produce a proinflammatory response (Th1) as antiinflammatory (Th2). Further studies are necessary to determine whether there is a preferential pathway activation.


Subject(s)
Humans , Adult , Macrophage Activation , Macrophages/immunology , Biomarkers/analysis , Chronic Periodontitis/pathology , Factor XIIIa/analysis , Immunohistochemistry , Interferon-gamma/analysis , /analysis , Chronic Periodontitis/immunology
18.
Rev Calid Asist ; 27(6): 341-4, 2012.
Article in Spanish | MEDLINE | ID: mdl-22537777

ABSTRACT

OBJECTIVES: To identify and classify disposable hospital products containing polyvinyl chloride (PVC), including the search and evaluation of cost-effective sustainable alternative products free of PVC. METHODS: A descriptive observational analysis was performed, after classifying the latest research in major databases, and disposable products that could contain PVC. These were divided into 5 groups: cannulas, catheters, tubes, bags, and equipment, purchased in the period 2008-2009, differentiating between the technical and economic assessment of the materials. RESULTS: In the analysis of the composition of 492 articles selected, 234 (47.5%) contained PVC, and 19.4% were considered PVC-free alternatives, with only 11.3% of these being economically viable. CONCLUSIONS: This study highlights the advantages of the classification of PVC products, by showing that safe and efficient alternatives exist for some product lines that are consistent with patient safety and quality in the work by doctors.


Subject(s)
Disposable Equipment/classification , Hospitals , Plastics/classification , Polyvinyl Chloride , Spain
19.
Ultrason Sonochem ; 19(3): 668-81, 2012 May.
Article in English | MEDLINE | ID: mdl-21963140

ABSTRACT

The influence on luminescence from conical bubble collapse (CBL) with varying Ar gas content while perturbing the liquid 1,2-Propanediol (PD) has been investigated. The temporal, spatial, and spectral features were analysed with regards to the dynamics of collapse and liquid degradation. Sulphuric acid and sodium chloride were added to disturb the liquid. The following three cases were studied: PD/Ar, (I), (PD + H(2)SO(4))/Ar, (II), and (PD + H(2)SO(4) + NaCl)/Ar, (III). The intensities of those cases decrease as III > II > I. Temporally, single and multiple light emissions were found to occur. The pulse shape exhibited a large variety of profiles with a main maximum and up to two local maxima around the main maximum. These local maxima resembled those generated by laser cavitation. Spatially, no radial symmetry was detected in the light emissions. Spectrally, the Swan, CH and CN lines were observed at low volumes of gas and driving pressure. The ·OH radical and OH-Ar bands, as well as the Na and K lines, consistently appeared superimposed on an underlying continuum that almost disappeared in (III). The Na line was observed with two satellite diffuse bands representing Na-Ar complexes in (I) and (II), whereas in (III), only the line of sodium could be seen. Weak and diffuse emission lines from the Ar atom in the near-IR region were observed in (I) and (II). The proposed mechanism of bright CBL was based on the energy transfer from electron-excited homolytic cleavage products to the chromophore molecules generated during the collapse-rebound time line (~8200 K and ~1 ms of collapse time from model), which had accumulated inside the liquid and remained on the walls of cavity during the repetition of the collapse. A general mechanism for the bright CBL is broached.


Subject(s)
Argon/chemistry , Argon/radiation effects , Luminescent Measurements/methods , Microbubbles , Sonication/methods , Gases/chemistry , Gases/radiation effects , High-Energy Shock Waves , Radiation Dosage , Spectrum Analysis , Temperature
20.
Arch. latinoam. nutr ; Arch. latinoam. nutr;61(4): 414-422, dic. 2011. ilus, graf, mapas, tab
Article in Spanish | LILACS | ID: lil-702750

ABSTRACT

El objetivo del estudio es conocer la sobrevivencia del probiótico Lactobacillus paracasei ssp paracasei agregado durante el procesamiento de Gauda semidescremado, durante maduración (21días) y en comercialización (14 días), así como la influencia de este organismo sobre la calidad del producto. Los tratamientos fueron: T1 (testigo): Gauda de contenido de grasa normal; T2: Queso Gauda semidescremado, QGS; T3: QGS, con probiótico adicionado junto al agregado del cultivo iniciador; T4: QGS, con probiótico adicionado al cocimiento de la cuajada. Para el recuento del probiótico se usó la metodología descrita por la Asociación de Salud Pública Americana (APHA), proteólisis por método de tirosina soluble en ácido tricloroacético (TCA) y, los análisis físicos y químicos por métodos estandarizados en Normas de la Federación Internacional de la Leche y Normas chilenas. Los recuentos obtenidos fueron de 108 ufc/g y 107 ufc/g en los quesos con adición del probiótico (T3 y T4, respectivamente) cerca del nivel de inóculo (108 ufc/g), durante el período de estudio (35días). La proteólisis se incrementó en forma normal y fue similar en todos los tratamientos durante los 35 días estudiados. Los tratamientos con reducción de grasa presentaron, aproximadamente, un 31% menos de grasa que el tratamiento testigo, y mayor humedad. Entre los tratamientos no se evidenció diferencias en sabor y apreciación general, en cambio los quesos con reducción de grasa resultaron más firmes, menos cohesivos y similares en elasticidad que el testigo.


The objective of this study is to infer the survival of the probiotic Lactobacillus paracasei ssp paracasei added during the processing of low-fat Gouda cheese during the maturation (21 days) and the commercialization (14 days), in order to see the influence that this organism has on the quality of the product. The treatments were: TI (control): Gouda with normal fat content; T2: Low fat Gouda cheese (QGS) T3: QGS, with additional probiotic added with the initial culture; T4: QGS, with the probiotic added in the cooking of the curd. For the count of the probiotic, the methodology was used set forth by the American Public Health Association, (APHA), proteolysis by the method of soluble tyrosine in trichloroacetic acid (TCA), and the physical and chemical analysis using the methods standardized by the International Dairy Federation, and Chilean normative. The counts obtained were from 108 ufc/g y 107 ufc/g in the cheeses that had the probiotic additive (T3 and T4, respectively) close to the level of innocuous (108 ufc/g) during the study period of 35 days. The proteolysis incremented normally, and was the same in all of the treatments during the 35 days studied. The treatments with fat-reduction presented approximately, 31% less fat than the control treatment, and also higher moistness. Within the treatments, there was no evidence of taste and general feel; in turn the cheeses with the reduction of fat resulted firmer, less cohesive, than the control, and with similar elasticity.


Subject(s)
Cheese/microbiology , Food Microbiology , Food Technology , Lactobacillus/physiology , Probiotics/analysis , Colony Count, Microbial , Taste
SELECTION OF CITATIONS
SEARCH DETAIL